Cheryl R. Blanchard - 14 Mar 2026 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Mar 2026, 19:42:01 UTC
Prior SEC filing
11 Mar 2026
Next SEC filing
16 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Cheryl R. Blanchard

Key filing fact

Cheryl R. Blanchard filed Form 4 for Anika Therapeutics, Inc. (ANIK) on 17 Mar 2026.

Key facts

  • This page summarizes Cheryl R. Blanchard's Form 4 filing for Anika Therapeutics, Inc. (ANIK).
  • 7 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 17 Mar 2026, 19:42.

Change

  • Previous filing in this sequence was filed on 11 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001326530 Primary reporting owner

Blanchard Cheryl R

Relationship
Director
Address
C/O ANIKA THERAPEUTICS, INC., 32 WIGGINS AVENUE, BEDFORD
Signature
/s/ Cheryl R. Blanchard
Signature date
17 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANIK transaction

Common Stock

Options Exercise

Transaction value
Shares
+24,519
Change %
+12%
Price
Shares after
235,969
Date
14 Mar 2026
Ownership
Direct
Footnotes
F1
ANIK transaction

Common Stock

Award

Transaction value
Shares
+24,520
Change %
+10%
Price
$0.000000*
Shares after
260,489
Date
14 Mar 2026
Ownership
Direct
Footnotes
F2
ANIK transaction

Common Stock

Tax liability

Transaction value
Shares
-14,728
Change %
-5.7%
Price
$14.20*
Shares after
245,761
Date
14 Mar 2026
Ownership
Direct
Footnotes
F3
ANIK transaction

Common Stock

Options Exercise

Transaction value
Shares
+25,131
Change %
+10%
Price
Shares after
270,892
Date
15 Mar 2026
Ownership
Direct
Footnotes
F1
ANIK transaction

Common Stock

Tax liability

Transaction value
Shares
-12,104
Change %
-4.5%
Price
$14.20*
Shares after
258,788
Date
15 Mar 2026
Ownership
Direct
Footnotes
F4
ANIK holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,742
Date
14 Mar 2026
Ownership
Revocable Trust
Footnotes
F5

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANIK transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-24,519
Change %
-33%
Price
$0.000000*
Shares after
49,040
Date
14 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
24,519
Exercise price
Footnotes
F1, F6
ANIK transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-25,131
Change %
-50%
Price
$0.000000*
Shares after
25,132
Date
15 Mar 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,131
Exercise price
Footnotes
F1, F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents the contingent right to receive one share of Issuer common stock.

Footnote F2

On March 14, 2025, the Reporting Person was granted 73,559 performance-based phantom RSUs ("PSUs") with vesting contingent upon the achievement of pre-established performance and strategic targets. This transaction represents the first vesting installment of such PSU award.

Footnote F3

Reflects an aggregate of 14,728 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs and PSUs that vested on March 14, 2026.

Footnote F4

Reflects an aggregate of 12,104 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 15, 2026.

Footnote F5

Consists of shares held by The Cheryl R. Blanchard Amended and Restated Revocable Trust dated December 19, 2014, of which the Reporting Person is a beneficiary and the sole trustee.

Footnote F6

On March 14, 2025, the Reporting Person was granted 73,559 RSUs vesting in three equal annual installments beginning on March 14, 2026. This transaction reflects the first vesting installment of such RSU award.

Footnote F7

On March 15, 2024, the Reporting Person was granted 75,395 RSUs vesting in three equal annual installments beginning on March 15, 2025. This transaction reflects the second vesting installment of such RSU award.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .